SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-036087
Filing Date
2023-11-02
Accepted
2023-11-01 18:18:11
Documents
12
Period of Report
2023-11-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K ocgn-20231102.htm   iXBRL 8-K 28273
  Complete submission text file 0001628280-23-036087.txt   153930

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20231102.xsd EX-101.SCH 1898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20231102_lab.xml EX-101.LAB 23834
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20231102_pre.xml EX-101.PRE 12506
6 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20231102_htm.xml XML 2712
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 231369461
SIC: 2836 Biological Products, (No Diagnostic Substances)